CoViD-19 Patient in Reims University Hospital in March to April 2020

NCT04553575 | Completed

• 1 other identifier: PO20124*
• Study Type: observational
• Target: 127
• Locations: 1 country
• Sites: 1

Brief Summary

Medical context: Follow-up of a retrospective cohort of 499 cases of CoViD-19, hospitalized at the University Hospital of Reims during the health crisis, prospectively up to two years of follow-up. Possible intervention for serological monitoring, leading to a change from category 3 to category 2 (French law on human person research) Aim of the study: To know the factors of gravity of CoViD-19, to know its prognostic factors, to see how the evolution of the treatments implemented have influenced the fate of the patients. Material and methods: Type of study: cohort study Population: Patients in the CoViD-19 cohort - Reims Calendar: September 2020 - July 2022 Expected results: Better knowledge of the cares of patients with CoViD-19

Conditions

Coronavirus Infections

Outcome Measures

Primary Outcomes (1)

• Health status in the 2 years after CoViD-19 diagnosis

  status : dead or alive persistante respiratory distress (yes / no)

  2 years follow up

Study Arms (1)

CoViD-19 patients cohort

Patients are followed for 2 years after diagnosis. The only one intervention is blood samples withdrawn for serologies

Biological: serology

Interventions

serology BIOLOGICAL

biological blood samples withdrawn at 6, 12 and 24 months

CoViD-19 patients cohort

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patient hospitalized for CoViD-19 infection during the health crisis, in a short-stay service of Reims University Hospital and included in Covid-19 Cohort

You may qualify if:

• Patient hospitalized for CoViD-19 infection during the health crisis, in a short-stay service of Reims University Hospital and included in Covid-19 Cohort
• Age \> 18 years
• Patient who benefit from the national health insurance coverage
• patient agree for participation (consent form signed)

You may not qualify if:

• Patient protected by law

Sponsors & Collaborators

• CHU de Reims: lead

Study Sites (1)

Chu Reims

Reims, 51092, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood samples

MeSH Terms

Conditions

Coronavirus Infections

Condition Hierarchy (Ancestors)

Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 2 Years
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 15, 2020
• First Posted: September 17, 2020
• Study Start: September 25, 2020
• Primary Completion: May 24, 2022
• Study Completion: August 4, 2022
• Last Updated: August 8, 2022

Record last verified: 2022-08

Locations

FR (1)